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A recent study of pneumococcal colonization in 3198 healthy children of 1–19 years of age in
The Netherlands showed pneumococcal colonization in 19 % of the children, with a peak incidence
of 55 % at the age of 2 years; an age-related serotype distribution was also found. In the present
study, the genetic background and resistance profiles of 578 pneumococcal isolates from the
latter study were characterized by means of chromosomal genotyping and susceptibility testing.
In contrast to the age-related serotype distribution observed previously, the genetic background of
the strains was not age related. Few strains were found showing close homology (>95 %) with the
international clones Spain9V-3 (ten isolates showed homology), England14-9 (four isolates),
Tennessee23F-4 (two isolates), CSR14-10 (one isolate) and Sweden15A-25 (one isolate). In total,
19 % of strains showed resistance to one or more antibiotics. Resistance to cotrimoxazole,
tetracycline, erythromycin and penicillin was found in 12?9, 5?6, 5?0 and 2?7 % of isolates,
respectively. Multidrug resistance was found in 1?9 % of strains. In conclusion, pneumococcal
colonization isolates from healthy Dutch children represent a heterogeneous, mostly antibiotic
susceptible, genetic population.
INTRODUCTION
Streptococcus pneumoniae is one of the major pathogens
causing invasive disease and respiratory tract infections
worldwide. Risk groups for pneumococcal infections are
young children, the elderly, and immunodeficient patients.
Despite adequate antibiotic treatment, morbidity and mor-
tality due to pneumococcal disease remain high (Butler et al.,
1999). In addition, the increasing (multi)drug resistance
among pneumococcal isolates hampers adequate treatment
(Centers for Disease Control and Prevention, 1997; Crook &
Spratt, 1998; Klugman, 1996; Tomasz, 1997).
Nasopharyngeal colonization with pneumococci is com-
mon; in general, humans are colonized at least once early in
life. Although colonization with pneumococci is mostly
asymptomatic, it can progress to respiratory or even sys-
temic disease as a result of a (temporary) defect in the
mucosal barrier function, e.g. as a result of a viral infection.
Importantly, pneumococcal disease has to be preceded by
nasopharyngeal colonization with the homologous strain
(Faden et al., 1990; Gray et al., 1980). Moreover, pneumo-
coccal colonization causes horizontal spread of this patho-
gen within the community; for example, crowding, which
occurs in hospitals, day-care centres and jails, enhances
horizontal spread of pneumococcal strains (Hoge et al.,
1994; Kristinsson, 1995;Mandigers et al., 1994; Mun˜oz et al.,
1991; Principi et al., 1999). Because the highest incidence
of pneumococcal colonization, and the highest crowding
index, are found in young children, this risk group is con-
sidered to be the most important vector for horizontal
dissemination of pneumococcal strains within the commu-
nity (Leiberman et al., 1999). New pneumococcal conjugate
vaccines are highly effective against invasive disease in young
children (Black et al., 2002). Furthermore, a protective effect
Abbreviations: MLST, multilocus sequence typing; PMEN, Pneumo-
coccal Molecular Epidemiological Network; RFEL, restriction fragment
end-labelling; ST, sequence type.
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against mucosal infections, such as (recurrent) otitis media,
albeit limited, has been observed (Black et al., 2002; Eskola
et al., 2001). At nasopharyngeal level, however, replacement
of vaccine-type pneumococci with non-vaccine serotypes, as
a result of vaccination, has also been observed (Dagan et al.,
2002; Mbelle et al., 1999; Veenhoven et al., 2003). In addi-
tion, replacement of mucosal disease, i.e. (recurrent) acute
otitis media, has been found (Eskola et al., 2001; Veenhoven
et al., 2003). What effect this serotype replacement has on
invasive disease remains unclear, although it has been
demonstrated that several non-vaccine serotypes clearly have
high potential for causing invasive disease (Brueggemann
et al., 2003). Because few data are available on the age-
related incidence and serotype distribution of S. pneumoniae
among healthy children, a cross-sectional study was per-
formed in the summer of 2002 among 3200 healthy children
aged 1–19 years, in which the prevalence and determinants
of pneumococcal carriage were studied (Bogaert et al.,
2003). That study showed a significant age-related coloniza-
tion rate, with a peak incidence of 55% at 3 years of age,
followed by a gradual decline to a stable colonization rate of
10%, which was reached after the age of 10 years. Moreover,
a significant age-related serotype distribution was noticed,
with a primary peak of 7-valent conjugate vaccine (7vPCV)
serotypes early in life, followed by a secondary peak with
non-vaccine serotypes (Bogaert et al., 2003).
In this study, we investigated the molecular epidemiological
dynamics and resistance profiles of the pneumococcal
strains collected during the latter study in order to obtain
detailed insight into the occurrence and age-related distri-
bution of pneumococcal genotypes and resistance profiles.
METHODS
Bacterial isolates. In total, 3198 healthy children, aged 1–19 years,
who were participating in a national meningococcal vaccination
campaign in Rotterdam, were enrolled. All children were residents
of Rotterdam, and were vaccinated either in July (age 12 months to
5 years, and 15–19 years) or September (age 6–15 years) of the year
2002. Signed informed consent was obtained from the parent
accompanying the participating children under the age of 16, and
directly from the children above the age of 16. Demographic data
were collected as described previously (Bogaert et al., 2003). The
study was approved by the Medical Ethics Review Board of Erasmus
MC, Rotterdam, The Netherlands.
Cultures. Nasopharyngeal samples were obtained with rayon-tipped
dacron pernasal swabs (Copan, Italy), transported in Amies trans-
port medium to the medical microbiology laboratory, and plated
within 6 h of sampling. The swabs were plated on gentamicin blood
agar for the isolation of S. pneumoniae. Identification of S. pneumo-
niae isolates was performed by standard methods, as described by
Lenette et al. (1985). The pneumococcal isolates were serotyped by
the capsular swelling method (Quellung reaction), using commer-
cially available antisera (Statens Serum Institute, Copenhagen,
Denmark). Susceptibility testing was performed by the disk-diffusion
method. Resistance was defined by measuring the zone diameters for
the respective antibiotics, as defined by the National Committee for
Clinical Laboratory Standards (NCCLS) (2002). Strains showing
reduced susceptibility to oxacillin were additionally tested for
penicillin and cefotaxime resistance by the Etest (AB Biodisk).
Multidrug resistance was defined as resistance to three or more
classes of antimicrobial agents.
Restriction fragment end-labelling (RFEL) typing. Pneumo-
coccal strain typing by RFEL was done as described by van
Steenbergen et al. (1995), and adapted by Hermans et al. (1995).
Briefly, purified pneumococcal DNA was digested by the restriction
enzyme EcoRI. The DNA restriction fragments were end-labelled
at 72 uC with [a-32P]dATP using DNA polymerase (Goldstar;
Eurogentec). After the radiolabelled fragments were denatured, and
separated electrophoretically on a 6% polyacrylamide sequencing gel
containing 8 M urea, the gel was transferred onto filter paper,
vacuum dried (HBI), and exposed for variable times at room tem-
perature to ECL hyperfilm (Amersham Laboratories).
Computer-assisted analysis of DNA band patterns. RFEL
autoradiographs were converted to images (Agfa Arcus II; Agfa
Gevaert), and analysed by computer (Windows version Bionumerics;
Applied Maths). DNA fragments were analysed as described pre-
viously (Sluijter et al., 1998). For evaluation of the genetic related-
ness of the isolates, we used the following definitions: isolates of a
particular RFEL type are 100% identical by RFEL analysis (Centers
for Disease Control Prevention, 1997); an RFEL cluster represents a
group of RFEL types that differ in only one band (approx. >95%
genetic relatedness) (Black et al., 2002).
Table 1. Serotype distribution of the pneumococcal isolates
Type Total number of pneumococci (%)
S. pneumoniae 601 (100%)
7vPCV types 250 (41?6%)
Non-vaccine types 351 (58?4%)
7vPCV types
Serotype 6B 69 (11?5%)
Serotype 19F 68 (11?3%)
Serotype 23F 53 (8?8%)
Serotype 14 23 (3?8%)
Serotype 18C 17 (2?8%)
Serotype 9V 14 (2?3%)
Serotype 4 6 (1?0%)
Non-vaccine types
Serotype 6A 40 (6?7%)
Serotype 3 36 (6?0%)
Serotype 11 31 (5?2%)
Serotype 8 21 (3?5%)
Serotype 15 19 (3?2%)
Serotype 19A 19 (3?2%)
Serotype 10 18 (3?0%)
Serotype 23A 16 (2?5%)
Serotype 16 12 (2?0%)
Serotype 38 12 (2?0%)
Serotype 7 10 (1?7%)
Other serotypes* 93 (15?4%)
UntypableD 31 (5?2%)
*Other serotypes were 1, 5, 9N, 12, 17, 18A, 19B, 20, 21, 22, 23B, 24,
29, 31, 33, 34, 35, 36, 37, 42, 44 and 47.
DThe 31 untypable strains were Omniserum positive, but unrespon-
sive to the available group or type sera.
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Fig. 1. Age-related serotype-specific prevalence of pneumococcal strains during colonization. The prevalence is depicted as a percentage of the total
number of children tested. Data are clustered for the ages 12–36 months, 3–6 years, 7–10 years, 11–14 years and 15–18 years.
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International comparison. The genotypes were compared with an
international collection of pneumococcal isolates representing 751
distinct RFEL types originating from 17 different countries in
America, Europe, Africa and Asia (Bogaert et al., 2002, 2005;
Hermans et al., 1997; Overweg et al., 2000), in which the first 26
international pandemic clones, as described by the Pneumococcal
Molecular Epidemiological Network (PMEN) in 2002, are present
(McGee et al., 2001).
Multilocus sequence typing (MLST). The genotypes of the 24
largest clusters (n>4) were verified by MLST analysis, and one, two
or three isolates per cluster were analysed. For this purpose, a fully
automated method for MLST was used, as described by Jefferies et al.
(2003). The MLST types were compared with the global PMEN data-
base (http://www.pneumo.com/physician/pmen/pmen_history.asp).
Data analysis. P values for differences were calculated with the x2
test, using GraphPad Prism version 3.00 for Windows (GraphPad
Software).
RESULTS
In total, 601 pneumococci were isolated from 3198 healthy
children aged 1–19 years visiting the meningococcal vacci-
nation campaign in the summer of 2002 in the city of
Rotterdam, The Netherlands. The most prevalent serotypes
were 6B, 19F, 23F, 6A, 3, 11 and 14 (Table 1). The age-
related distribution of the most prevalent serotypes is
depicted in Fig. 1. The 7vPCV serotypes, as well as the cross-
protective serotypes, invariably showed peak incidences at
the age of 1–2 years, whereas the incidence of themajority of
the non-vaccine serotypes peaked at an older age.
A total of 578 (96%) of the pneumococci were available for
genetic analysis by means of RFEL genotyping. We observed
337 genetically distinct genotypes, of which 153 genotypes
were unique (i.e. found once only). The remaining 425
pneumococcal isolates (74%) comprised 92 genetic clusters.
Of the RFEL clusters observed in our collection, five showed
close homology with RFEL profiles of the international
PMEN clones. The PMEN genotype Spain9V-3 was observed
ten times, England14-9 four times, Tennessee23F-4 two times,
CSR14-10 once and Sweden15A-25 once. In Fig. 2, all genetic
clusters are represented in a genetic dendrogram, which
includes the serotype distribution, age distribution, and
number of isolates representing each cluster. In contrast to
the age-related serotype distribution, the dendrogram sug-
gests no additional correlation between age and genetic
profile, except for cluster I, which showed a mean age of
11 years, compared with 6 years for the entire pneumo-
coccal population.
In Table 2, we list the nine largest genetic clusters, each
representing more than ten isolates. The largest cluster,
cluster V, consisted of 45 strains of serotype 6B (Veenhoven
et al., 2003), 6A (Butler et al., 1999) and 19F (Black et al.,
2002), representing five genotypes. No homology was
observed with any of the PMEN clones. The second and
third largest clusters, cluster VIII (18 strains) and cluster I
(17 strains), represented two and three genotypes, respec-
tively, and harboured mainly serotype 3. Only one major
cluster, cluster IX, representing serotypes 9V and 19F (13
strains), showed close homology (>95%) with an inter-
national clone, which was Spain9V-3. MLST analysis showed
that cluster IX and Spain9V-3 had five out of seven alleles in
common. In contrast to the original PMEN clone, all Dutch
isolates were fully susceptible to penicillin, tetracycline,
erythromycin and cotrimoxazole. The remaining clusters,
i.e. cluster II (13 strains), cluster III (10 strains), cluster IV
(13 strains), cluster VI (10 strains) and cluster VII (12
strains), represented predominantly the serotypes 14, 15,
Fig. 2. Dendrogram of the 92 genetic clusters observed by RFEL genotyping among the Dutch S. pneumoniae
nasopharyngeal isolates. The figure shows serotypes (with number of strains per serotype in parentheses), bars representing
the mean ages of children carrying the isolates, number of isolates per RFEL cluster, and cluster codes. NT, not typable.
Table 2. Properties of the most predominant genetic clusters
NT, not typable.
Cluster Number of
isolates
Serotype Number of
genotypes
Mean age
(years)*
I 17 3 (3), 8 (6), NT (3), others (6) 3 11
II 13 14 (8), others (5) 4 4
III 10 15 (6), others (4) 2 6
IV 13 23F (13) 4 3
V 45 6B (35), 6A (8), 19F (2) 5 4
VI 10 23F (8), others (2) 3 5
VII 12 23F (8), 17 (2), others (2) 3 4
VIII 18 3 (17), others (1) 2 7
IX 13 9V (5), 19F (6), others (2) 4 5
*Mean age of the children carrying the isolates.
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23F, 23F and 23F, respectively. Six of the nine major clusters
consisted of 7vPCV serotypes, whereas only three clusters
represented the non-vaccine serotypes 3 and 15.
We characterized the 24 largest clusters by MLST (Fig. 3).
This method confirmed the presence of an additional PMEN
clone, namely England14-9. The remaining clusters showed
sequence types (STs) differing from the international
multidrug-resistant clones; however, most clusters matched
STs present in the international database.
Susceptibility testing was performed on 587 pneumococcal
isolates for the following antimicrobial drugs: penicillin,
erythromycin, tetracycline, cotrimoxazole, chloramphenicol,
cefotaxime, ciprofloxacin and vancomycin. In total, 18?1%of
the isolates showed resistance to one or more of the anti-
microbial drugs investigated. Resistance to cotrimoxazole,
erythromycin and tetracycline was found in 12?9, 5?0 and
5?6% of isolates, respectively. Resistance to vancomycin and
ciprofloxacin was not observed. In 13?6% of the isolates,
resistance to a single drug was observed. In 2?6% of the
isolates, dual resistance was found, and multidrug resistance
was found in 1?9% of isolates. High-level penicillin resistance
was not observed; however, 2?7% of the pneumococcal
isolates showed intermediate susceptibility to penicillin. In
addition, the majority of these strains (11 out of 15 isolates)
showed dual or multidrug resistance. Table 3 gives the
number of strains, resistance level, and the mean ages of the
Fig. 3. Dendrogram of 35 representative pneumococcal strains belonging to the 24 largest clusters. The MLST profiles of
these strains are depicted. *100 % homology with England14-9; 35 out of 7 alleles showed homology with Spain9V-3.
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children carrying these isolates. No significant difference was
observed for the mean ages of the children carrying resistant
isolates (5?4 years) versus children carrying susceptible
isolates (5?9 years), or for the individual resistance profiles.
We also determined the contribution of 7vPCV serotypes
to the total number of resistant strains. Sixty out of 104
resistant strains belonged to serotypes covered by the 7-
valent conjugate vaccine (58%), and 74 out of 104 resistant
isolates (71%) were found to be vaccine serotype isolates
when the cross-protective serotypes 6A, 9N/L, 19A/B and
23A/B were included; in both cases, the contribution of
7vPCV serotypes to resistance was significantly higher
compared with the contribution of 7vPCV serotypes to the
total group of pneumococci. In case of dual resistance 10
out of 15 (67%) displayed 7vPCV serotypes and 11 out of
15 isolates (73%) when cross-protective serotypes were
included. With respect to multidrug resistance, 6 out of 11
(55%) strains represented 7vPCV serotypes, and 7 out of 11
(64%) represented 7vPCV serotypes when cross-reactive
serotypes were included; however, numbers were too small
to show significant differences compared with the con-
tribution of 7vPCV serotypes to the susceptible pneumo-
coccal population.
DISCUSSION
We studied the molecular epidemiology of 578 pneumo-
coccal isolates retrieved from healthy children ranging from
12 months to 19 years of age in Rotterdam, The Nether-
lands. Genetic clustering was observed in 74% of the strains,
which comprised 92 distinct genetic clusters. These data
indicate both a high genetic diversity among pneumococci,
and horizontal spread within the community. Moreover,
because the majority of the strains were fully susceptible to
the most common antibiotics, these data suggest that
horizontal spread is by definition not related to (multi)drug
resistance, as stated previously. Since the prevalence of
resistant pneumococci was very low (18?1%), we were
unable to compare the tendency to spread within the
community between resistant and fully susceptible strains
within this population.
In our cohort, the largest genetic cluster comprised mainly
serotype 6A and 6B isolates. These isolates were fully
susceptible to penicillin, tetracycline, erythromycin and
cotrimoxazole. In addition, comparison of the genotypes of
this cluster showed no close homology with any of the
known serotype 6B clones from the PMEN database (McGee
et al., 2001). Of the genotypes observed in our collection,
only five showed close homology with five distinct PMEN
clones (McGee et al., 2001). These data indicate that the
international drug-resistant clones do not significantly
contribute to colonization and spread of pneumococci
among children in The Netherlands. The data confirm the
observations of recent studies performed in TheNetherlands
among day-care-centre attendees, and children suffering
from recurrent acute otitis media (Bogaert et al., 2001,
2005).
Recently, we observed an age-related pneumococcal sero-
type distributionwithin our study population (Bogaert et al.,
2003). Pneumococcal 7vPCV serotypes showed an initial
peak incidence of 30% at the age of 1 year, after which a
decline was observed to an incidence of 2–3% after the age
of 8 years. For non-vaccine serotypes, an initial increase in
incidence was observed to 27% at the age of 4 years,
followed by a decline, which stabilized after the age of
15 years at 4% (Bogaert et al., 2003). This was mainly
caused by the predominance of a limited number of
predominant non-vaccine serotypes after the age of 3 years,
i.e. serotypes 3, 8, 10 and 11. Children under 2 years of age
show the highest risk for pneumococcal infections, and
since these children carry mainly 7vPCV serotype strains, a
difference in virulence between 7vPCV and non-vaccine
serotypes might exist. Therefore, we investigated the age-
related distribution of genotypes. In contrast to the pre-
dominant serotype 3 cluster I with a mean age of 11 years,
no age-related genetic clustering was observed. This obser-
vation supports the analyses of Brueggemann and Sandgren
who reported that pneumococcal serotype and host factors,
such as age, might be more important than genetic back-
ground in the progression of colonization to disease (Crook
& Spratt, 1998; Sandgren et al., 2004).
When evaluating the nine largest clusters, each harbouring
10 or more isolates, we observed that six of these clusters
Table 3. Susceptibility profiles of the pneumococcal isolates
Antibiotic Resistant
strains*
Intermediate-resistant
strains*
Total* Mean age
(years)D
Penicillin 0?0% 2?7% 2?7% 7?1
Tetracycline 3?9% 1?7% 5?6% 5?9
Erythromycin 4?5% 0?6% 5?0% 5?1
Cotrimoxazole 7?5% 5?5% 12?9% 5?7
Chloramphenicol 0?2% 0?0% 0?2% 18?0
*Values are percentages of the total number of strains tested.
DMean age of the children carrying the isolates.
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represented the conjugate vaccine serotypes 6B, 14 and 23F,
whereas the remaining three clusters consisted of the non-
vaccine serotypes 3, 8 and 15. These data suggest that besides
7vPCV serotype pneumococci, non-vaccine pneumococcal
serotypes are also able to spread at high frequency within the
community. These findings are in accordance with several
vaccination studies, in which replacement of 7vPCV sero-
types with non-vaccine pneumococcal serotype carriage was
found in the nasopharynx after vaccination with a pneumo-
coccal conjugate vaccine (Dagan et al., 2002; Mbelle et al.,
1999; Veenhoven et al., 2003). However, the question
remains whether these non-vaccine serotype strains are as
pathogenic as their 7vPCV-serotype counterparts. Several
studies have shown that replacement of 7vPCV serotypes
with non-vaccine serotype pneumococci can cause mucosal
disease (Eskola et al., 2001; Veenhoven, 2003); with respect
to invasive disease, replacement has not yet been observed.
However, Brueggemann et al. (2003) have demonstrated
epidemiological evidence for the high invasive capacity of
certain non-vaccine serotypes.
In 18?1%of the strains studied, susceptibility testing showed
resistance to at least one of the most commonly used anti-
microbial drugs. Resistance to a single drug was observed
most often (13?6%), and multidrug resistance was found in
only 1?9% of the isolates. Most commonly, we observed
resistance to cotrimoxazole (12?9%), which is a first-line
antibiotic used commonly in children in The Netherlands.
Finally, we found antibiotic resistance to be associated with
7vPCV-serotype pneumococci, which is in line with pre-
vious studies (Bogaert et al., 2002; Dobay et al., 2003;
Watanabe et al., 2003).
We have established that drug resistance, with respect to
pneumococcal carriage and disease, is still of minor concern
in The Netherlands; however, a strict policy with respect to
antibiotic prescription is still required.
In conclusion, pneumococcal colonization isolates from
healthy Dutch children represent a heterogeneous genetic
population of mostly susceptible strains, which display a
high tendency to spread horizontally, irrespective of the age
of the colonized children.
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